RECRUITING

Dietary Reporting In The Amyloidoses

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis. The main question it aims to answer is: Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients Participants will be asked to: * Download the MyFitnessPal application on their smartphone and view an online tutorial * After a week of practice, from weeks 2-9, participants will enter daily dietary intake as well as daily herbal/alternative supplement intake into the MyFitnessPal application on their smartphone. * complete a questionnaire prior to starting the application, after week 2 and at week 10 after starting the application

Official Title

DRITA Pilot Trial: Dietary Reporting in the Amyloidoses

Quick Facts

Study Start:2023-03-02
Study Completion:2025-11-21
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05738005

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years of age or older
  2. * Diagnosed with any type of amyloidosis
  3. * Speak, read and write in English
  4. * Willing to use the MyFitnessPal app on their own smartphone
  1. * a planned autologous stem cell transplant or a solid organ transplant in the 12 weeks after enrollment
  2. * cognitive or perceptual disturbances

Contacts and Locations

Study Contact

Jeffrey Zonder, MD
CONTACT
313-576-8732
zonderj@karmanos.org

Principal Investigator

Jeffrey Zonder, MD
PRINCIPAL_INVESTIGATOR
Barbara Ann Karmanos Cancer Institute

Study Locations (Sites)

Karmanos Cancer Institute
Detroit, Michigan, 48201
United States

Collaborators and Investigators

Sponsor: Barbara Ann Karmanos Cancer Institute

  • Jeffrey Zonder, MD, PRINCIPAL_INVESTIGATOR, Barbara Ann Karmanos Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-03-02
Study Completion Date2025-11-21

Study Record Updates

Study Start Date2023-03-02
Study Completion Date2025-11-21

Terms related to this study

Additional Relevant MeSH Terms

  • Amyloidosis